Clinical trial Recruiting at 1 site Observational Ages 6 to 100

Study on urethroplasty for urethral stricture disease

Official title: 9000 URETHRA STUDY: a Prospective, Observational Study About Urethroplasty for Urethral Stricture Disease

Run by University Hospital, Ghent · NCT04071925 · Data updated 2026-11-12

This study is testing how well urethroplasty works for treating urethral stricture disease in different groups of people, including men, women, transgender individuals, and children.

Quick facts

Study typeObservational
Ages6 Years to 100 Years
SexAll
Enrollment1000 (estimated)
SponsorUniversity Hospital, Ghent
Academic / other
Locations2 sites (Ghent and 1 other locations)
StatusRecruiting
StartedSeptember 1, 2019
Main results expectedDecember 31, 2029
Study endsDecember 31, 2029
Registry record updatedJanuary 3, 2024
Trial IDNCT04071925 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged 6 years and older who are facing potential treatment for urethral stricture disease.

Probably not a fit

Patients who are unwilling to provide informed consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to gather prospective evidence on the effectiveness of urethroplasty as a treatment for urethral stricture disease, which is considered the gold standard due to its higher long-term success rates compared to other treatments. It will include diverse patient groups, such as native men, native women, transmen, transwomen, and children, to ensure comprehensive data collection. The study will focus on understanding outcomes across these subgroups to address biases present in previous retrospective studies.

Why it matters

Potential benefit: If successful, this study could provide robust evidence supporting urethroplasty as the preferred treatment for urethral stricture disease, leading to improved patient outcomes.

How similar studies have gone: While many studies have focused on urethroplasty, this study's prospective approach aims to fill gaps left by previous retrospective analyses, making it a novel contribution to the field.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations.
* Patient age ≥ 6 years.
* If a patient reaches the age of 18 years, he or she will have to provide a new voluntarily signed written informed consent. All patients reaching the age of 18 years will be contacted by the Principal Investigator or Subinvestigator to provide a new voluntarily signed written informed consent.

Exclusion Criteria:

\- Absence of signed written informed consent and thus a patient unwilling to participate.

Where it's running

  • University Hospital Ghent
    Ghent, Belgium
    Recruiting
  • Dept. of Urology, Ghent University Hospital
    Ghent, Belgium
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.